Shin-ichi Araki
- Associate Professor, Department of Internal Medicine (Diabetology, Endocrinology and Nephrology)
- 1. Clinical studies for diabetic nephropathy
2. Exploring new biomarkers for diabetic nephropathy
3. Exploring novel therapeutic strategies for diabetic vascular complications
CV
1990 Resident, Third Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan
1997 Ph.D.(Medical Science), Shiga University of Medical Science, Otsu, Shiga, Japan
1997-2000 Research Fellow, Joslin Diabetes Center, Harvard Medical School, MA, USA
2004 Assistant Professor, Department of Medicine (Diabetology, Endocrinology and Nephrology), Shiga University of Medical Science
2010 Senior Assistant Professor, Department of Medicine (Diabetology, Endocrinology and Nephrology), Shiga University of Medical Science
2016 Associate Professor, Department of Medicine (Diabetology, Endocrinology and Nephrology), Chief of hemodialysis unit (blood purification)
, Shiga University of Medical Science
Message
We are doing the clinical and basic studies to overcome diabetic vascular complications with young fellows and students.
Publication
1. Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 54:2983-2987, 2005
2. Araki S, Haneda M, Koya D, Hidaka H, Sugimoto T, Isono M, Isshiki K, Chin-Kanasaki M, Uzu T, Kashiwagi A. Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes mellitus. Diabetes 56:1727-1730, 2007
3. Araki S, Haneda M, Koya D, Isshiki K, Kume S, Sugimoto T, Kawai H, Nishio Y, Kashiwagi A, Uzu T, Maegawa H. Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria. Diabetes Care 33:1805-1810, 2010
4.
Araki S, Haneda M, Koya D, Sugaya T, Isshiki K, Kume S, Kashiwagi A, Uzu T, Maegawa H. Predictive effects of urinary liver-type fatty-acid binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy. Diabetes Care 36:1248-1253, 2013
5.
Araki S, Haneda M, Koya D, Kondo K, Tanaka S, Arima H, Kume S, Nakazawa J, M Chin-Kanasaki, Ugi S, Kawai H, Araki H, Uzu T, Maegawa H. Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function. Clin J Am Soc Nephrol 10: 2152-2158, 2015
Link